Eylea and Blind - a phase IV clinical study of FDA data
Summary:
Blind is reported as a side effect among people who take Eylea (aflibercept), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lucentis, and have Age-related macular degeneration.
The phase IV clinical study analyzes which people have Blind when taking Eylea. It is created by eHealthMe based on reports of 27,819 people who have side effects when taking Eylea from the FDA, and is updated regularly.
What is Eylea?
Eylea has active ingredients of aflibercept. It is often used in macular degeneration. eHealthMe is studying from 27,868 Eylea users. Check the latest studies of Eylea.
What is Blind?
Blind is found to be associated with 2,442 drugs and 1,951 conditions by eHealthMe. Check the latest studies of Blind.
27,819 people reported to have side effects when taking Eylea.
Among them, 1,532 people (5.51%) have Blind.
Among these 1,532 people:
How long have people been on Eylea when they have Blind? *
- < 1 month: 82.06 %
- 1 - 6 months: 4.07 %
- 6 - 12 months: 4.31 %
- 1 - 2 years: 5.26 %
- 2 - 5 years: 3.59 %
- 5 - 10 years: 0.72 %
- 10+ years: 0.0 %
What is the gender of people who have Blind when taking Eylea? *
- female: 60.8 %
- male: 39.2 %
What is the age of people who have Blind when taking Eylea? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.82 %
- 30-39: 0.0 %
- 40-49: 2.87 %
- 50-59: 11.07 %
- 60+: 85.25 %
What are other drugs people take besides Eylea? *
- Lucentis: 236 people, 15.40%
- Avastin: 93 people, 6.07%
- Beovu: 26 people, 1.70%
- Amlodipine: 23 people, 1.50%
- Betadine: 22 people, 1.44%
- Metformin: 21 people, 1.37%
- Calcium: 14 people, 0.91%
- Vabysmo: 13 people, 0.85%
- Insulin: 11 people, 0.72%
- Simvastatin: 10 people, 0.65%
What are other side effects people have besides Blind? *
- Visual Impairment: 278 people, 18.15%
- Endophthalmitis (inflammation of the internal coats of the eye): 274 people, 17.89%
- Eye Pain: 138 people, 9.01%
- Intraocular Pressure Increased: 106 people, 6.92%
- Vision Blurred: 104 people, 6.79%
- Eye Inflammation: 95 people, 6.20%
- Drug Ineffective: 75 people, 4.90%
- Eye Haemorrhage (bleeding in the eye): 72 people, 4.70%
- Vitritis (inflammation of the vitreous humour of the eye): 67 people, 4.37%
- Vitreous Floaters (spots before the eyes): 65 people, 4.24%
What are the existing conditions these people have? *
- Age-Related Macular Degeneration: 209 people, 13.64%
- Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 195 people, 12.73%
- Retinal Vessel Occlusion (a blockage in one of the small arteries): 86 people, 5.61%
- Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 72 people, 4.70%
- Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 40 people, 2.61%
- Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 36 people, 2.35%
- High Blood Pressure: 25 people, 1.63%
- Pain: 16 people, 1.04%
- Asthma: 15 people, 0.98%
- Glaucoma (increased fluid pressure in the eye with vision loss): 10 people, 0.65%
* Approximation only. Some reports may have incomplete information.
Do you take Eylea and have Blind?
- Check whether Blind is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Eylea:
- Eylea (27,868 reports)
Blind treatments and more:
- Blind (45,948 reports)
How severe was Blind and when was it recovered:
Expand to all the drugs that have ingredients of aflibercept:
- Blind and drugs with ingredients of aflibercept (1,539 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Common Eylea side effects:
- Eylea side effect: Death (8,962 reports)
- Eylea side effect: Visual impairment (1,905 reports)
- Eylea side effect: Endophthalmitis (inflammation of the internal coats of the eye) (1,352 reports)
- Eylea side effect: Visual acuity reduced (reduced clearness of vision) (1,251 reports)
- Eylea side effect: Blindness unilateral (1,158 reports)
- Eylea side effect: Vision blurred (1,134 reports)
- Eylea side effect: Blindness transient (sudden loss of vision) (1,097 reports)
Browse all side effects of Eylea:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon drugs associated with Blind:
- Prednisone side effect: Blind (1,919 reports)
- Humira side effect: Blind (1,851 reports)
- Aspirin side effect: Blind (1,796 reports)
- Humalog side effect: Blind (1,719 reports)
- Lantus side effect: Blind (1,629 reports)
- Eylea side effect: Blind (1,532 reports)
- Metformin side effect: Blind (1,255 reports)
- Omeprazole side effect: Blind (1,219 reports)
- Simvastatin side effect: Blind (1,178 reports)
- Methotrexate side effect: Blind (1,119 reports)
Browse all the drugs that are associated with Blind:
- Blind (2,442 drugs)
Common conditions associated with Blind:
- Ms: 3,572 reports
- Ra: 2,156 reports
- Diabetes mellitus: 1,985 reports
- Diabetes: 1,914 reports
- Dm: 1,913 reports
- Hypertension: 1,565 reports
- Blood pressure increased: 1,563 reports
- Type 2 diabetes: 1,347 reports
- Auricular fibrillation: 1,103 reports
- Heart fibrillation: 1,102 reports
Browse all the conditions that are associated with Blind:
- Blind (1,951 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on aflibercept (the active ingredients of Eylea) and Eylea (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Amlodipine Besylate and Policosanol - a second ago
- Vitamins and Seborrhoeic Keratosis for Women aged 60+ - 4 seconds ago
- Could Phenergan cause Arrhythmias? - 4 seconds ago
- Drug interactions of Avandia and Centrum - 22 seconds ago
- Drug interactions of Pletal and Miralax - 25 seconds ago
- Could Marinol cause Herpes Zoster? - 29 seconds ago
- Drug interactions of Baclofen and Dymista - 31 seconds ago
- Fish Oil and Esomeprazole Sodium drug interactions for women aged 60+ - 32 seconds ago
- Drug interactions of Lisinopril And Hydrochlorothiazide and Progesterone - 36 seconds ago
- Drug interactions of Cipro and Ancef - 47 seconds ago